InChI=1S/C22H34O5/c1- 2- 3- 4- 5- 6- 7- 9- 14- 19(23) 15- 12- 13- 17- 21(25) 20(24) 16- 10- 8- 11- 18- 22(26) 27/h3- 4,6- 7,9,12- 15,17,19- 21,23- 25H,2,5,8,10- 11,16,18H2,1H3,(H,26,27) /b4- 3- ,7- 6- ,14- 9+,15- 12+,17- 13+ |
BCZZVMYJQJPMKV-DGIURTQMSA-N |
CC/C=C\C/C=C\C=C\C(/C=C/C=C/C(C(CCCCCC(=O)O)O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(9E,11E,14E,16Z,19Z)- 7,8,13- trihydroxydocosa- 9,11,14,16,19- pentaenoic acid
|
(9E,11E,14E,16Z,19Z)-7,8,13-trihydroxydocosapentaenoic acid
|
ChEBI
|
13-series resolvin 3
|
ChEBI
|
RvT3
|
ChEBI
|
26236990
|
PubMed citation
|
Europe PMC
|
27704804
|
PubMed citation
|
Europe PMC
|
|